Вінницький національний медичний університет імені М.І. Пирогова
Вінницький національний медичний університет імені М.І. Пирогова
National Pirogov Memorial Medical University, Vinnytsya
Verified email at vnmu.edu.ua - Homepage
TitleCited byYear
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
K Swedberg, M Komajda, M Böhm, JS Borer, I Ford, A Dubost-Brama, ...
The Lancet 376 (9744), 875-885, 2010
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ...
New England Journal of Medicine 376 (18), 1713-1722, 2017
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ...
N Engl j Med 369, 1327-1335, 2013
Long-term use of ticagrelor in patients with prior myocardial infarction
MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ...
New England Journal of Medicine 372 (19), 1791-1800, 2015
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
K Fox, I Ford, PG Steg, M Tendera, R Ferrari, Beautiful Investigators
The Lancet 372 (9641), 807-816, 2008
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1238-1251, 2008
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis
RJ Fox, DH Miller, JT Phillips, M Hutchinson, E Havrdova, M Kita, M Yang, ...
New England Journal of Medicine 367 (12), 1087-1097, 2012
Dapagliflozin and cardiovascular outcomes in type 2 diabetes
SD Wiviott, I Raz, MP Bonaca, O Mosenzon, ET Kato, A Cahn, ...
New England Journal of Medicine 380 (4), 347-357, 2019
Telmisartan to prevent recurrent stroke and cardiovascular events
S Yusuf, HC Diener, RL Sacco, D Cotton, S Ôunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1225-1237, 2008
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
G Roe, M.T., Armstrong, P.W., Fox, K.A.A., (...), Rafael, A., Aycock
New England Journal of Medicine, 2012
Rivaroxaban with or without aspirin in stable cardiovascular disease
JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ...
New England Journal of Medicine 377 (14), 1319-1330, 2017
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with …
DH Yoo, P Hrycaj, P Miranda, E Ramiterre, M Piotrowski, S Shevchuk, ...
Annals of the rheumatic diseases 72 (10), 1613-1620, 2013
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised …
IM Jacobson, GJ Dore, GR Foster, MW Fried, M Radu, VV Rafalsky, ...
The Lancet 384 (9941), 403-413, 2014
Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia
DL Bhatt, PG Steg, M Miller, EA Brinton, TA Jacobson, SB Ketchum, ...
New England Journal of Medicine 380 (1), 11-22, 2019
Alirocumab and cardiovascular outcomes after acute coronary syndrome
GG Schwartz, PG Steg, M Szarek, DL Bhatt, VA Bittner, R Diaz, ...
New England Journal of Medicine 379 (22), 2097-2107, 2018
Ivabradine in stable coronary artery disease without clinical heart failure
K Fox, I Ford, PG Steg, JC Tardif, M Tendera, R Ferrari
New England Journal of Medicine 371 (12), 1091-1099, 2014
Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
JC Tardif, P Ponikowski, T Kahan
European heart journal 30 (5), 540-548, 2009
Effect of linagliptin monotherapy on glycaemic control and markers of β‐cell function in patients with inadequately controlled type 2 diabetes: a randomized …
S Del Prato, AH Barnett, H Huisman, D Neubacher, HJ Woerle, KA Dugi
Diabetes, Obesity and Metabolism 13 (3), 258-267, 2011
Darapladib for preventing ischemic events in stable coronary heart disease
Stability Investigators
New England Journal of Medicine 370 (18), 1702-1711, 2014
The system can't perform the operation now. Try again later.
Articles 1–20